These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 19290981

  • 1. Chronic lymphocytic leukaemia: current first-line therapy.
    Carney DA, Mulligan SP.
    Intern Med J; 2009 Jan; 39(1):44-8. PubMed ID: 19290981
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chronic lymphocytic leukemia in the elderly population.
    Rai KR.
    Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
    [Abstract] [Full Text] [Related]

  • 5. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
    Swords R, Nolan A, Fay M, Quinn J, O'Donnell R, Murphy PT.
    Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemoimmunotherapy of chronic lymphocytic leukemia.
    Tam CS, Keating MJ.
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):479-98. PubMed ID: 17707835
    [Abstract] [Full Text] [Related]

  • 8. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
    Robak T, Kasznicki M.
    Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibodies in chronic lymphocytic leukemia.
    Ferrajoli A, Faderl S, Keating MJ.
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment].
    Bauduer F.
    Presse Med; 2009 Jan; 38(1):140-2. PubMed ID: 19004611
    [No Abstract] [Full Text] [Related]

  • 12. What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
    Byrd JC, Rai KR.
    Semin Oncol; 2000 Aug; 27(4):xii-xv; discussion xv-xvi. PubMed ID: 10950363
    [No Abstract] [Full Text] [Related]

  • 13. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
    Foon KA, Boyiadzis M, Land SR, Marks S, Raptis A, Pietragallo L, Meisner D, Laman A, Sulecki M, Butchko A, Schaefer P, Lenzer D, Tarhini A.
    J Clin Oncol; 2009 Feb 01; 27(4):498-503. PubMed ID: 19075274
    [Abstract] [Full Text] [Related]

  • 14. [Current principles of diagnosis and treatment of chronic lymphocytic B-cell leukemia].
    Losonczy H.
    Orv Hetil; 1998 Mar 15; 139(11):611-9. PubMed ID: 9545794
    [Abstract] [Full Text] [Related]

  • 15. Rituximab. Chronic lymphoid leukaemia: no decisive advantage.
    Prescrire Int; 2010 Apr 15; 19(106):56-8. PubMed ID: 20568482
    [Abstract] [Full Text] [Related]

  • 16. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S, Christou L, Konstantinidou P, Panteli A, Briasoulis E, Bourantas KL.
    Am J Hematol; 1997 Apr 15; 54(4):342. PubMed ID: 9092698
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of chronic lymphocytic leukemia.
    Ferrajoli A, O'Brien SM.
    Semin Oncol; 2004 Apr 15; 31(2 Suppl 4):60-5. PubMed ID: 15124136
    [Abstract] [Full Text] [Related]

  • 18. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
    Ural AU, Kubar A, Avcu F, Tastan HB, Safali M, Nevruz O, Cetin T.
    Clin Exp Dermatol; 2007 Mar 15; 32(2):151-4. PubMed ID: 17244344
    [Abstract] [Full Text] [Related]

  • 19. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
    Wilhelm K, Yang D.
    J Oncol Pharm Pract; 2011 Jun 15; 17(2):91-103. PubMed ID: 20085962
    [Abstract] [Full Text] [Related]

  • 20. Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
    Eichhorst BF, Busch R, Schweighofer C, Wendtner CM, Emmerich B, Hallek M, German CLL Study Group (GCLLSG).
    Br J Haematol; 2007 Jan 15; 136(1):63-72. PubMed ID: 17083342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.